IR@PKUHSC  > 北京大学第三临床医学院  > 内分泌科
学科主题临床医学
Coronary Flow Velocity Reserve is Improved by PPAR- Agonist Fenofibrate in Patients with Hypertriglyceridemia
Wang, Guang1,2,3; He, Liyun2,3; Liu, Jinbo1; Yu, Jie2,3; Feng, Xinheng2,3; Li, Fuwang4; Hao, Yanting2,3; Mao, Jieming2,3; Hong, Tianpei1; Chen, Alex F.5; Wang, Xian4
关键词Coronary flow velocity reserve Endothelial function Homocysteine PPAR-alpha
刊名CARDIOVASCULAR THERAPEUTICS
2013-06-01
DOI10.1111/j.1755-5922.2011.00307.x
31期:3页:161-167
收录类别SCI
文章类型Article
WOS标题词Science & Technology
类目[WOS]Cardiac & Cardiovascular Systems ; Pharmacology & Pharmacy
资助者Major National Basic Research Program of P. R. China ; Chinese National Natural Science Foundation ; Major National Basic Research Program of P. R. China ; Chinese National Natural Science Foundation
研究领域[WOS]Cardiovascular System & Cardiology ; Pharmacology & Pharmacy
关键词[WOS]TYPE-2 DIABETES-MELLITUS ; ARTERY ENDOTHELIAL FUNCTION ; PEROXISOME-PROLIFERATOR ; NITRIC-OXIDE ; ATHEROSCLEROSIS ; DISEASE ; ALPHA ; GAMMA ; STIFFNESS ; HYPERHOMOCYSTEINEMIA
英文摘要

Introduction: Fenofibrate, an agonist of peroxisome proliferator-activated receptor- (PPAR-), has a vascular protective effect. Aims: We investigated the effect of the PPAR- agonist on coronary artery endothelial function in patients with hypertriglyceridemia. Methods: Fifty-eight patients with hypertriglyceridemia were divided into two groups: control (no treatment; n = 23) and fenofibrate treatment (n = 35), 200 mg/d, for 6 months. The patients had undergone rest and adenosine treatment to induce hyperemia for quantification of coronary flow velocity reserve (CFVR) by noninvasive Doppler echocardiography before treatment and at 6-month follow-up. Pulse wave velocity (PWV) was measured before treatment and at 6-month follow-up. Results: CFVR was significantly improved with fenofibrate treatment as compared with baseline level and control group (3.14 +/- 0.36 vs. 2.80 +/- 0.58 and 2.79 +/- 0.65, P < 0.01 and 0.05, respectively), with no difference between baseline levels and untreated controls. In addition, at 6 months, plasma level of homocysteine was significantly increased with fenofibrate treatment as compared with at baseline and control group (median 18.13 [range 14.4622.02]mol/L vs. 14.09 [12.0118.81] and 13.34 [9.6917.06]mol/L, P < 0.001 and 0.01, respectively). Furthermore, at 6 months, PWV was significantly decreased with fenofibrate treatment as compared with control group (1446 +/- 136 cm/s vs. 1570 +/- 203 cm/s, P < 0.05). Conclusions: Treatment with PPAR- agonist fenofibrate significantly improved CFVR and arterial stiffness in patients with hypertriglyceridemia. This endothelial protective effect may be reduced in part by the side effect of increasing homocysteine.

语种英语
所属项目编号2011CB503904 ; 30730042 ; 30821001 ; 81070701 ; 30770873 ; 81070244
资助者Major National Basic Research Program of P. R. China ; Chinese National Natural Science Foundation ; Major National Basic Research Program of P. R. China ; Chinese National Natural Science Foundation
WOS记录号WOS:000318039100007
引用统计
被引频次:9[WOS]   [WOS记录]     [WOS相关记录]
文献类型期刊论文
条目标识符http://ir.bjmu.edu.cn/handle/400002259/62722
专题北京大学第三临床医学院_内分泌科
作者单位1.Peking Univ, Hosp 3, Dept Endocrinol, Beijing 100191, Peoples R China
2.Peking Univ, Hosp 3, Dept Cardiol, Beijing 100191, Peoples R China
3.Peking Univ, Hosp 3, Minist Hlth, Key Lab Cardiovasc Mol Biol & Regulatory Peptides, Beijing 100191, Peoples R China
4.Peking Univ, Key Lab Mol Cardiovasc Sci, Dept Physiol & Pathophysiol, Sch Basic Med Sci,Minist Educ,Hlth Sci Ctr, Beijing 100191, Peoples R China
5.Univ Pittsburgh, Dept Surg, Sch Med & Vasc Surg Res, Pittsburgh, PA USA
推荐引用方式
GB/T 7714
Wang, Guang,He, Liyun,Liu, Jinbo,et al. Coronary Flow Velocity Reserve is Improved by PPAR- Agonist Fenofibrate in Patients with Hypertriglyceridemia[J]. CARDIOVASCULAR THERAPEUTICS,2013,31(3):161-167.
APA Wang, Guang.,He, Liyun.,Liu, Jinbo.,Yu, Jie.,Feng, Xinheng.,...&Wang, Xian.(2013).Coronary Flow Velocity Reserve is Improved by PPAR- Agonist Fenofibrate in Patients with Hypertriglyceridemia.CARDIOVASCULAR THERAPEUTICS,31(3),161-167.
MLA Wang, Guang,et al."Coronary Flow Velocity Reserve is Improved by PPAR- Agonist Fenofibrate in Patients with Hypertriglyceridemia".CARDIOVASCULAR THERAPEUTICS 31.3(2013):161-167.
条目包含的文件
条目无相关文件。
个性服务
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Wang, Guang]的文章
[He, Liyun]的文章
[Liu, Jinbo]的文章
百度学术
百度学术中相似的文章
[Wang, Guang]的文章
[He, Liyun]的文章
[Liu, Jinbo]的文章
必应学术
必应学术中相似的文章
[Wang, Guang]的文章
[He, Liyun]的文章
[Liu, Jinbo]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。